µoª¢©Ê¸z¹D¯e¯fPSA­È¤Ó°ª¡@¤p¤ß«e¦C¸¢Àù¤W¨­

2018-12-14 1862

µoª¢©Ê¸z¹D¯e¯f¬O¤@ºØ¸z¹Dµo¥ÍºC©Êµoª¢ªº¯e¯f¡A¦nµo©ó¼Ú¬ü¤H¤h¡AµM¦Ó¦b¥xÆW¤]¤£ºâ¨u¨£¡A¨C¦~·s½T¶E®×¨Ò¬ù5¦Ê¤H¡A²±¦æ²v©Mµo¥Í²v³£¦³¼W¥[ªºÁͶաC¬ü°ê¦è¥_¤j¾Ç¤é«e¤@¶µªø¹F20¦~ªº¬ã¨s«ü¥X¡A¦³µoª¢©Ê¸z¹D¯e¯fªº¨k©Ê¡A³Q¶EÂ_¥X«e¦C¸¢(ÄáÅ@¸¢)Àùªº¾÷²v°ª¥X4¦Ü5­¿¡C

µoª¢©Ê¸z¹D¯e¯f(Inflammatory Bowel Disease)¬O¤@ºØ¸z¹Dµo¥ÍºC©Êµoª¢ªº¯e¯f¡A¦nµo©ó¼Ú¬ü¤H¤h¡AµM¦Ó¦b¥xÆW¤]¤£ºâ¨u¨£¡A¨C¦~·s½T¶E®×¨Ò¬ù5¦Ê¤H¡A²±¦æ²v©Mµo¥Í²v³£¦³¼W¥[ªºÁͶաC¬ü°ê¦è¥_¤j¾Ç¤é«e¤@¶µªø¹F20¦~ªº¬ã¨s«ü¥X¡A¦³µoª¢©Ê¸z¹D¯e¯fªº¨k©Ê¡A³Q¶EÂ_¥X«e¦C¸¢(ÄáÅ@¸¢)Àùªº¾÷²v°ª¥X4¦Ü5­¿¡C

¦è¥_¤j¾Çªâ³ùÂå¾Ç°|§U²z±Ð±ÂShilajit KunduÂå®v«ü¥X¡A­Yµoª¢©Ê¸z¹D¯e¯fªº¨k©Ê³QÀË´ú¥X¹L°ªªº«e¦C¸¢¯S²§§Ü­ì(Prostate Specific Antigen, PSA)¡A¥i¯à¬O«e¦C¸¢Àùªº«e¥ü¡C

µoª¢©Ê¸z¹D¯e¯f¤À2Ãþ¡@¾É­P¦hºØ°·±d°ÝÃD

®Ú¾Ú¥xÆWµoª¢©Ê¸z¹D¯e¯f¯f¤Í·|¸ê®Æ¡Aµoª¢©Ê¸z¹D¯e¯f¤À¬°¼ìºÅ©Êµ²¸zª¢(Ulcerative colitis)¤Î§J¶©¤ó¯g(Crohn¡¦s disease)¨âÃþ¡C¼ìºÅ©Ê¤j¸zª¢¥D­nµo¥Í¦b¤j¸z¡]µ²¸z¡^©Îª½¸z¡A§J¶©¤ó¯g«h¦nµo©ó¥½¬q¤p¸z¡A¦ý¤]¥i¯à«I¥Ç¨ì¾ã­Ó®ø¤Æ¹D(±q¤fµÄ¨ì¨zªù)¡C±`¨£ªº¯gª¬¦³¨{¤lµh¡B®É±`¸¡Âm¡B¦å«K¡Bµo¿N¡B¯h¾Î¡BÅé­«´î»´¡B­i½¤ª¢©Î¥Ö½§¥X²{¬õ´³µ¥¡C¬ÛÃöªº¨Öµo¯g¥]¬A³h¦å¡BÀç¾i¯Ê¥F¡B°©½è²¨ÃP¡BÃö¸`ª¢©M¨xª¢µ¥¯gª¬¡C

¥xÆW²±¦æ²v¼W¡@¦hºØÃĪ«¥iªvÀø

µoª¢©Ê¸z¹D¯e¯fªºµo¯f¾÷ÂàÁÙ¤£²M·¡¡A¦ý»P±wªÌªº°ò¦]¡B¥Í¬¡Àô¹Ò»P§K¬Ì¨t²Î¦³Ãö¡C¾Ú1998¦~¨ì2010¦~¥xÆW¥þ¥Á°·±d«OÀI¸ê®Æ®wÅã¥Ü¡Aµoª¢©Ê¸z¹D¯e¯f±wªÌ¤H¼Æ¨C¦~³v¦~¼W¥[¡Aª½¨ì2007-2010¦~¤~ÁÍ©óí©w¡A¨ä¤¤¼ìºÅ©Ê¤j¸zª¢²×¥Í²Ö¿nµo¥Í²v¬O0.066%¡A§J¶©¤ó¯g«h¬°0.013%¡A¦nµo©ó10-30·³¡A¥t¤@µo¯f°ª®p¦b50-80·³¡C

Á{§É±`¥Î¶EÂ_¡A¥]¬A¤ºµøÃèÀˬd(¤j¸zÃè¡B¤p¸zÃè)¡B¼v¹³¾ÇÀˬd(¾X¾¯Äá¼v¡B¹q¸£Â_¼h¡B®ÖºÏ¦@®¶)©M¦å²G¤Î¥Í¤ÆÀˬd¡C¸Ó¯e¯f¦³§Üµoª¢ÃĪ«¥~¡AÃþ©T¾J¡B§K¬Ì½Õ¸`¾¯¡A¬Æ¦Ü¸û·sªº¥Íª«¾Ç»s¾¯¦pAnti-TNFµ¥ÃĪ«¥i¨Ñ¿ï¾Ü¡A­Y¯f±¡¸ûÄY­«¡A«h¥²¶·¶i¦æ¤â³N¡C

ª`·NPSA¼Æ­È¡@«e¦C¸¢Àù«e¥ü

¦è¥_¤j¾Çµoªí¦b¡m¼Ú¬wªc§¿¥~¬ì¡n(European Urology)ªº¬ã¨sªá¶O18¦~¡A°lÂÜ1,033¦W¿©±wµoª¢©Ê¸z¹D¯e¯fªº¨k©Ê»P9,306¥¿±`¨k©Ê¡C¸g¹L¬Û¤¬¤ñ¸û«á¡A¬ã¨sÅã¥Ü¡A¿©±wµoª¢©Ê¸z¹D¯e¯fªº¨k©Ê¸û®e©ö±o¨ì«e¦C¸¢Àù¡A¨ÃÀË´ú¥X¸û°ªªºPSA­È¡C

¡u¿©±wµoª¢©Ê¸z¹D¯e¯fªº¨k©ÊÀ³§óÂÔ·V¿zÀË«e¦C¸¢Àù¡C¡vShilajit KunduÂå®v¦V¡m¬ì¾Ç¤é³ø¡nªí¥Ü¡A®Ú¾Ú¥LªºÁ{§É¸gÅç¡A¥L¬Ý¹L¤Ó¦hµoª¢©Ê¸z¹D¯e¯fªº¨k©Ê¦³¹L°ªªºPSA­È¡CµM¦Ó³\¦hÂå®v»{¬°¡APSA­È¤É°ª¶È¶È¥u¬O¤Ï¬Mµoª¢ªº±¡ªp¡A¦Ó¥B¹L¥h¨Ã¨S¦³¥ô¦ó¸ê®Æ«ü¤Þ³o¨ÇÂå®v«áÄò³B²z¡C¥¼¨Ó¬ã¨s¹Î¶¤±N¶i¤@¨B½Õ¬d¸z¹Dµoª¢¤Þ°_«e¦C¸¢Àùªº­ì¦]¡C

°Ñ¦Ò¸ê®Æ¡G

1. Jacob A. Burns et al. Inflammatory Bowel Disease and the Risk of Prostate Cancer. European Urology, 2018; DOI: 10.1016/j.eururo.2018.11.039
2. Inflammatory bowel disease linked to prostate cancer.

¥»¤å¸g °·±dÂåÀøºô ±ÂÅv¥Zµn¡A­ì¤åµoªí©ó¦¹
¡i°·±dÂåÀøºô¡þ°OªÌ½²©¨§»³ø¾É¡j2018/12/14

ment,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-35937129-1', 'auto'); ga('send', 'pageview');